Evidence map›Paper›PMID 24856822›Full record

ArticleChemistry & biology2014

Defining estrogenic mechanisms of bisphenol A analogs through high throughput microscopy-based contextual assays.

Fabio Stossi, Michael J Bolt, Felicity J Ashcroft, Jane E Lamerdin, Jonathan S Melnick, Reid T Powell, Radhika D Dandekar, Maureen G Mancini, Cheryl L Walker, John K Westwick and 1 more

Abstract read
In one paragraph

Article in Chemistry & biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Bisphenols-A Threat to the Natural Environment.Materials (Basel, Switzerland) · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Fabio StossiDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Michael J BoltDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Felicity J AshcroftDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Jane E LamerdinOdyssey Thera, San Ramon, CA 94583, USA.
Jonathan S MelnickOdyssey Thera, San Ramon, CA 94583, USA.
Reid T PowellInstitute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX 77030, USA.
Radhika D DandekarDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Maureen G ManciniDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Cheryl L WalkerInstitute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX 77030, USA.
John K WestwickOdyssey Thera, San Ramon, CA 94583, USA.
Michael A ManciniDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: mancini@bcm.edu.
Baylor College of Medicine · USTexas A&M Health Science Center · USOdyssey House · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Michael M Ittmann · 2007 to 2026
$73.9M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI James Versalovic · 2001 to 2026
$28.3M
TRANSGENIC MOUSE MODELS TO STUDY OVARIAN FUNCTIONU54HD007495 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI MATZUK, MARTIN M. · 1998 to 2013
$19.9M
TARGETED GENOMICS FACILITY COREP30ES023512 · NIEHS · TEXAS A&M AGRILIFE RESEARCH · PI THREADGILL, DAVID W. · 2014 to 2017
$3.3M
Epigenetic Programmers Targeted During Developmental ReprogrammingR01ES023206 · NIEHS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI BEDFORD, MARK T., MANCINI, MICHAEL A. · 2013 to 2016
$2.3M
Developmental Reprogramming of Prostate Carcinogenesis by BPARC2ES018789 · NIEHS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HO, SHUK-MEI, MANCINI, MICHAEL A. · 2009 to 2010
$1.9M
GROWTH AND DIFFERENTIATION IN EUKARYOTEST32HD007495 · NICHD · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI KINTNER, CHRISTOPHER ROBERT · 1995 to 2009
$1.6M
TRANSGENIC ANIMAL--COREP30HD007495 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI GLASSER, STANLEY R · 1985 to 1997
–
NCI NIH HHS CA125123NCI NIH HHS P30 CA125123NICHD NIH HHS HD007495NICHD NIH HHS P30 HD007495NICHD NIH HHS T32 HD007495NICHD NIH HHS U54 HD007495NIDDK NIH HHS DK56338NIDDK NIH HHS P30 DK056338NIEHS NIH HHS 1R01ES023206-01NIEHS NIH HHS 1RC2ES018789-01NIEHS NIH HHS ES023512-01NIEHS NIH HHS P30 ES023512NIEHS NIH HHS R01 ES023206NIEHS NIH HHS RC2 ES018789
6 · The paper itself

Abstract

Environmental exposures to chemically heterogeneous endocrine-disrupting chemicals (EDCs) mimic or interfere with hormone actions and negatively affect human health. Despite public interest and the prevalence of EDCs in the environment, methods to mechanistically classify these diverse chemicals in a high throughput (HT) manner have not been actively explored. Here, we describe the use of multiparametric, HT microscopy-based platforms to examine how a prototypical EDC, bisphenol A (BPA), and 18 poorly studied BPA analogs (BPXs), affect estrogen receptor (ER). We show that short exposure to BPA and most BPXs induces ERα and/or ERβ loading to DNA changing target gene transcription. Many BPXs exhibit higher affinity for ERβ and act as ERβ antagonists, while they act largely as agonists or mixed agonists and antagonists on ERα. Finally, despite binding to ERs, some BPXs exhibit lower levels of activity. Our comprehensive view of BPXs activities allows their classification and the evaluation of potential harmful effects. The strategy described here used on a large-scale basis likely offers a faster, more cost-effective way to identify safer BPA alternatives.

Indexed as

High-Throughput Screening AssaysBenzhydryl CompoundsBisphenol A CompoundsCell ProliferationDose-Response Relationship, DrugEstrogen Receptor alphaEstrogen Receptor betaHeLa CellsHumansMCF-7 CellsMicroscopyPhenolsStructure-Activity RelationshipTumor Cells, CulturedBenzhydryl Compoundsbisphenol ABisphenol A CompoundsEstrogen Receptor alphaEstrogen Receptor betaPhenols

Identifiers

PMID24856822
PMCPMC4301571
OpenAlexW2088832076

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.